Anthony Petrone
Stock Analyst at Mizuho Securities
(4.60)
# 1,007
Out of 5,073 analysts
676
Total ratings
53.8%
Success rate
8.6%
Average return
Main Sectors:
Stocks Rated by Anthony Petrone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ISRG Intuitive Surgical | Reiterated: Hold | $415 → $400 | $428.12 | -6.57% | 20 | Oct 21, 2026 | |
| BSX Boston Scientific | Rated: Buy | $60 → $55 | $44.51 | +23.57% | 26 | Oct 13, 2026 | |
| SWX: ALC Alcon Inc. | Reiterated: Buy | CHF 70.73 → CHF 66.57 | CHF 55.92 | +19.05% | 26 | Oct 13, 2026 | |
| DXCM DexCom | Rated: Buy | $95 → $100 | $80.26 | +24.60% | 15 | Oct 13, 2026 | |
| GKOS Glaukos | Rated: Buy | $185 | $176.85 | +4.61% | 28 | Oct 13, 2026 | |
| INSP Inspire Medical Systems | Rated: Buy | $65 → $75 | $71.07 | +5.53% | 21 | Oct 13, 2026 | |
| LNTH Lantheus Holdings | Downgraded: Hold | $115 → $109 | $100.24 | +8.74% | 38 | Oct 13, 2026 | |
| PLSE Pulse Biosciences | Rated: Buy | $45 → $55 | $51.31 | +7.19% | 7 | Oct 13, 2026 | |
| RMD ResMed | Rated: Buy | $235 → $240 | $246.20 | -2.52% | 33 | Oct 13, 2026 | |
| TFX Teleflex | Rated: Hold | $145 → $140 | $130.40 | +7.36% | 24 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $20 → $18 | $16.34 | +10.16% | 9 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 → $140 | $117.11 | +19.55% | 72 | Oct 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $28 | $17.80 | +57.30% | 5 | Oct 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 → $75 | $58.97 | +27.18% | 40 | Sep 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $115 | $93.03 | +23.62% | 29 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $78.44 | - | 29 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 → $58 | $36.48 | +58.99% | 4 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 → $85 | $69.01 | +23.17% | 21 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $13.05 | +68.58% | 2 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $4.37 | +243.25% | 1 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $17 | $11.01 | +54.41% | 34 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $105 | $62.28 | +68.59% | 31 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $105 | $88.40 | +18.78% | 30 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $18 | $7.97 | +125.85% | 6 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $22 → $27 | $21.61 | +24.94% | 31 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $7 | $3.05 | +129.51% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 → $5 | $6.68 | -25.15% | 7 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $8 | $3.74 | +113.90% | 20 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $125 → $115 | $100.51 | +14.42% | 20 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $67.76 | +47.58% | 1 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $166.66 | n/a | 1 | Jun 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $175 | $94.86 | n/a | 2 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $70 | $83.67 | n/a | 1 | Sep 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 | $1.08 | n/a | 3 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $45 | $70.50 | n/a | 7 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $86 | $11.84 | n/a | 1 | May 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $5.35 | n/a | 1 | Sep 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 → $18 | $18.42 | n/a | 8 | Aug 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.000001 | n/a | 5 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $6 | $0.137 | n/a | 7 | Aug 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $80 → $95 | - | n/a | 4 | Mar 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $93 | $196.93 | n/a | 1 | Aug 25, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $97 | $15.91 | n/a | 1 | Aug 2, 2016 |
Intuitive Surgical
Oct 21, 2026
Reiterated: Hold
Price Target: $415 → $400
Current: $428.12
Upside: -6.57%
Boston Scientific
Oct 13, 2026
Rated: Buy
Price Target: $60 → $55
Current: $44.51
Upside: +23.57%
Alcon Inc.
Oct 13, 2026
Reiterated: Buy
Price Target: CHF 70.73 → CHF 66.57
Current: CHF 55.92
Upside: +19.05%
DexCom
Oct 13, 2026
Rated: Buy
Price Target: $95 → $100
Current: $80.26
Upside: +24.60%
Glaukos
Oct 13, 2026
Rated: Buy
Price Target: $185
Current: $176.85
Upside: +4.61%
Inspire Medical Systems
Oct 13, 2026
Rated: Buy
Price Target: $65 → $75
Current: $71.07
Upside: +5.53%
Lantheus Holdings
Oct 13, 2026
Downgraded: Hold
Price Target: $115 → $109
Current: $100.24
Upside: +8.74%
Pulse Biosciences
Oct 13, 2026
Rated: Buy
Price Target: $45 → $55
Current: $51.31
Upside: +7.19%
ResMed
Oct 13, 2026
Rated: Buy
Price Target: $235 → $240
Current: $246.20
Upside: -2.52%
Teleflex
Oct 13, 2026
Rated: Hold
Price Target: $145 → $140
Current: $130.40
Upside: +7.36%
Oct 13, 2026
Rated: Hold
Price Target: $20 → $18
Current: $16.34
Upside: +10.16%
Oct 9, 2026
Reiterated: Buy
Price Target: $95 → $140
Current: $117.11
Upside: +19.55%
Oct 8, 2026
Reiterated: Buy
Price Target: $26 → $28
Current: $17.80
Upside: +57.30%
Sep 11, 2026
Reiterated: Buy
Price Target: $85 → $75
Current: $58.97
Upside: +27.18%
Sep 2, 2026
Reiterated: Buy
Price Target: $100 → $115
Current: $93.03
Upside: +23.62%
Aug 21, 2026
Reiterated: Buy
Price Target: n/a
Current: $78.44
Upside: -
Jul 31, 2026
Reiterated: Buy
Price Target: $55 → $58
Current: $36.48
Upside: +58.99%
Jul 31, 2026
Reiterated: Buy
Price Target: $80 → $85
Current: $69.01
Upside: +23.17%
Jul 28, 2026
Reiterated: Buy
Price Target: $22
Current: $13.05
Upside: +68.58%
Jul 17, 2026
Initiated Coverage: Buy
Price Target: $15
Current: $4.37
Upside: +243.25%
Jul 15, 2026
Reiterated: Buy
Price Target: $20 → $17
Current: $11.01
Upside: +54.41%
Jul 15, 2026
Reiterated: Buy
Price Target: $100 → $105
Current: $62.28
Upside: +68.59%
Jul 15, 2026
Reiterated: Buy
Price Target: $100 → $105
Current: $88.40
Upside: +18.78%
Jul 15, 2026
Reiterated: Buy
Price Target: $20 → $18
Current: $7.97
Upside: +125.85%
May 14, 2026
Reiterated: Hold
Price Target: $22 → $27
Current: $21.61
Upside: +24.94%
May 7, 2026
Reiterated: Buy
Price Target: $8 → $7
Current: $3.05
Upside: +129.51%
May 6, 2026
Reiterated: Hold
Price Target: $12 → $5
Current: $6.68
Upside: -25.15%
Apr 30, 2026
Reiterated: Buy
Price Target: $10 → $8
Current: $3.74
Upside: +113.90%
Apr 20, 2026
Reiterated: Hold
Price Target: $125 → $115
Current: $100.51
Upside: +14.42%
Apr 13, 2026
Reiterated: Buy
Price Target: $100
Current: $67.76
Upside: +47.58%
Jun 13, 2025
Reiterated: Buy
Price Target: $65
Current: $166.66
Upside: n/a
Nov 5, 2021
Reiterated: Buy
Price Target: $175
Current: $94.86
Upside: n/a
Sep 16, 2021
Rated: Buy
Price Target: $70
Current: $83.67
Upside: n/a
Aug 11, 2021
Rated: Buy
Price Target: $20
Current: $1.08
Upside: n/a
Aug 10, 2021
Rated: Buy
Price Target: $45
Current: $70.50
Upside: n/a
May 20, 2021
Rated: Buy
Price Target: $86
Current: $11.84
Upside: n/a
Sep 17, 2020
Initiated Coverage: Buy
Price Target: $15
Current: $5.35
Upside: n/a
Aug 13, 2020
Reiterated: Hold
Price Target: $25 → $18
Current: $18.42
Upside: n/a
Dec 3, 2019
Reiterated: Buy
Price Target: $7
Current: $0.000001
Upside: n/a
Aug 17, 2018
Reiterated: Buy
Price Target: $7 → $6
Current: $0.137
Upside: n/a
Mar 5, 2018
Reiterated: Hold
Price Target: $80 → $95
Current: -
Upside: n/a
Aug 25, 2017
Reiterated: Buy
Price Target: $93
Current: $196.93
Upside: n/a
Aug 2, 2016
Reiterated: Hold
Price Target: $97
Current: $15.91
Upside: n/a